TY - JOUR
T1 - Neuronal damage by secretory phospholipase A2
T2 - modulation by cytosolic phospholipase A2, platelet-activating factor, and cyclooxygenase-2 in neuronal cells in culture
AU - Kolko, Miriam
AU - Rodriguez de Turco, Elena B
AU - Diemer, Nils H
AU - Bazan, Nicolas G
PY - 2003/2/27
Y1 - 2003/2/27
N2 - Activation of cytosolic phospholipase A(2) (cPLA(2)) is an early event in brain injury, which leads to the formation and accumulation of bioactive lipids: platelet-activating factor (PAF), free arachidonic acid, and eicosanoids. A cross-talk between secretory PLA(2) (sPLA(2)) and cPLA(2) in neural signal transduction has previously been suggested (J Biol Chem 271:32722; 1996). Here we show, using neuronal cell cultures, an up-regulation of cPLA(2) expression and an inhibition by the selective cPLA(2) inhibitor AACOCF3 after exposure to neurotoxic concentrations of sPLA(2)-OS2. Pretreatment of neuronal cultures with recombinant PAF acetylhydrolase (rPAF-AH) or the presynaptic PAF receptor antagonist, BN52021, partially blocked neuronal cell death induced by sPLA(2)-OS2. Furthermore, selective COX-2 inhibitors ameliorated sPLA(2)-OS2-induced neurotoxicity. We conclude that sPLA(2)-OS2 activates a neuronal signaling cascade that includes activation of cPLA(2), arachidonic acid release, PAF production, and induction of COX-2.
AB - Activation of cytosolic phospholipase A(2) (cPLA(2)) is an early event in brain injury, which leads to the formation and accumulation of bioactive lipids: platelet-activating factor (PAF), free arachidonic acid, and eicosanoids. A cross-talk between secretory PLA(2) (sPLA(2)) and cPLA(2) in neural signal transduction has previously been suggested (J Biol Chem 271:32722; 1996). Here we show, using neuronal cell cultures, an up-regulation of cPLA(2) expression and an inhibition by the selective cPLA(2) inhibitor AACOCF3 after exposure to neurotoxic concentrations of sPLA(2)-OS2. Pretreatment of neuronal cultures with recombinant PAF acetylhydrolase (rPAF-AH) or the presynaptic PAF receptor antagonist, BN52021, partially blocked neuronal cell death induced by sPLA(2)-OS2. Furthermore, selective COX-2 inhibitors ameliorated sPLA(2)-OS2-induced neurotoxicity. We conclude that sPLA(2)-OS2 activates a neuronal signaling cascade that includes activation of cPLA(2), arachidonic acid release, PAF production, and induction of COX-2.
KW - 1-Alkyl-2-acetylglycerophosphocholine Esterase
KW - Animals
KW - Arachidonic Acids/pharmacology
KW - Cell Death/drug effects
KW - Cells, Cultured
KW - Cyclooxygenase 2
KW - Cyclooxygenase 2 Inhibitors
KW - Cyclooxygenase Inhibitors/pharmacology
KW - Cytosol/metabolism
KW - Diterpenes
KW - Embryo, Mammalian/cytology
KW - Enzyme Induction
KW - Ginkgolides
KW - Isoenzymes/biosynthesis
KW - L-Lactate Dehydrogenase/metabolism
KW - Lactones/pharmacology
KW - Neurons/cytology
KW - Neurotoxins/pharmacology
KW - Phospholipases A/antagonists & inhibitors
KW - Phospholipases A2
KW - Platelet Activating Factor/biosynthesis
KW - Platelet Membrane Glycoproteins/antagonists & inhibitors
KW - Prostaglandin-Endoperoxide Synthases/biosynthesis
KW - Rats
KW - Receptors, Cell Surface/antagonists & inhibitors
KW - Receptors, G-Protein-Coupled
KW - Recombinant Proteins/pharmacology
KW - Reptilian Proteins
KW - Up-Regulation
U2 - 10.1016/s0304-3940(02)01385-x
DO - 10.1016/s0304-3940(02)01385-x
M3 - Journal article
C2 - 12566178
SN - 0304-3940
VL - 338
SP - 164
EP - 168
JO - Neuroscience Letters
JF - Neuroscience Letters
IS - 2
ER -